Cargando…

Robust Ensemble Classification Methodology for I123-Ioflupane SPECT Images and Multiple Heterogeneous Biomarkers in the Diagnosis of Parkinson's Disease

In last years, several approaches to develop an effective Computer-Aided-Diagnosis (CAD) system for Parkinson's Disease (PD) have been proposed. Most of these methods have focused almost exclusively on brain images through the use of Machine-Learning algorithms suitable to characterize structur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castillo-Barnes, Diego, Ramírez, Javier, Segovia, Fermín, Martínez-Murcia, Francisco J., Salas-Gonzalez, Diego, Górriz, Juan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102321/ https://www.ncbi.nlm.nih.gov/pubmed/30154711 http://dx.doi.org/10.3389/fninf.2018.00053

Ejemplares similares

Comparison between Different Intensity Normalization Methods in (123)I-Ioflupane Imaging for the Automatic Detection of Parkinsonism
por: Brahim, A., et al.
Publicado: (2015)

Correction: Comparison between Different Intensity Normalization Methods in (123)I-Ioflupane Imaging for the Automatic Detection of Parkinsonism
por: Brahim, A., et al.
Publicado: (2015)

Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses
por: Badoud, Simon, et al.
Publicado: (2016)

CT-Based Attenuation Correction in I-123-Ioflupane SPECT
por: Lange, Catharina, et al.
Publicado: (2014)

Bipolar Disorder and Parkinson's Disease: A (123)I-Ioflupane Dopamine Transporter SPECT Study
por: Erro, Roberto, et al.
Publicado: (2021)

Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson’s Disease
por: ASAHI, Takashi, et al.
Publicado: (2016)

(123)I-ioflupane brain SPECT and (123)I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders
por: Nuvoli, Susanna, et al.
Publicado: (2017)

The role of (123)I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies
por: Antonini, Angelo
Publicado: (2007)

Impact of the cerebrospinal fluid-mask algorithm on the diagnostic performance of (123)I-Ioflupane SPECT: an investigation of parkinsonian syndromes
por: Iwabuchi, Yu, et al.
Publicado: (2019)

Diagnostic Effectiveness of [(123)I]Ioflupane Single Photon Emission Computed Tomography (SPECT) in Multiple System Atrophy
por: Villena-Salinas, Javier, et al.
Publicado: (2023)

Functional Brain Imaging Synthesis Based on Image Decomposition and Kernel Modeling: Application to Neurodegenerative Diseases
por: Martinez-Murcia, Francisco J., et al.
Publicado: (2017)

Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of (123)I-Ioflupane SPECT in Assessing Clinical Symptoms of Drug-Naïve Parkinson’s Disease Patients
por: Murakami, Hidetomo, et al.
Publicado: (2018)

A Heavy Tailed Expectation Maximization Hidden Markov Random Field Model with Applications to Segmentation of MRI
por: Castillo-Barnes, Diego, et al.
Publicado: (2017)

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2013)

Clinical Comparison of (99m)Tc Exametazime and (123)I Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain Injury
por: Newberg, Andrew B., et al.
Publicado: (2014)

Preprocessing of (18)F-DMFP-PET Data Based on Hidden Markov Random Fields and the Gaussian Distribution
por: Segovia, Fermín, et al.
Publicado: (2017)

Accumulation of (123)I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Naïve Parkinson’s Disease
por: Murakami, Hidetomo, et al.
Publicado: (2017)

Reduced 123I Ioflupane Binding in Bilateral Diabetic Chorea: Findings With 18F FDG PET, 99mTc ECD SPECT, and 123I MIBG Scintigraphy
por: Sato, Kenichiro, et al.
Publicado: (2016)

Patient Survey on Satisfaction and Impact of 123I-Ioflupane Dopamine Transporter Imaging
por: Covington, Matthew F., et al.
Publicado: (2015)

Interpreting (123)I–ioflupane dopamine transporter scans using hybrid scores
por: Nichols, Kenneth J., et al.
Publicado: (2018)

Safety, biodistribution and radiation dosimetry of [(123)I]ioflupane in healthy Chinese volunteers
por: Zhang, Min, et al.
Publicado: (2023)

Follow-Up Findings in Multiple System Atrophy from [(123)I]Ioflupane Single-Photon Emission Computed Tomography (SPECT): A Prospective Study
por: Villena-Salinas, Javier, et al.
Publicado: (2023)

Association between body mass index (BMI) and [(123)I]Ioflupane (DaTSCAN) availabilities in patients with parkinsonism using single-photon emission computed tomography–computed tomography (SPECT-CT)
por: Parekh, Puja, et al.
Publicado: (2023)

Rest Tremor Pattern Predicts DaTscan ( (123)I‐Ioflupane) Result in Tremulous Disorders
por: Quattrone, Andrea, et al.
Publicado: (2021)

Diagnosis of Parkinson syndrome and Lewy-body disease using (123)I-ioflupane images and a model with image features based on machine learning
por: Nakajima, Kenichi, et al.
Publicado: (2022)

Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials
por: O'Brien, John T, et al.
Publicado: (2014)

Focal (123)I-FP-CIT SPECT Abnormality in Midbrain Vascular Parkinsonism
por: Solla, Paolo, et al.
Publicado: (2015)

Multivariate Analysis of (18)F-DMFP PET Data to Assist the Diagnosis of Parkinsonism
por: Segovia, Fermín, et al.
Publicado: (2017)

Extrastriatal (123)I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort
por: Nicastro, Nicolas, et al.
Publicado: (2020)

Bipolar Disorder and Parkinson disease: a 123I-FP-CIT SPECT study
por: D’agostino, G., et al.
Publicado: (2023)

Distinguishing Parkinson's disease from atypical parkinsonian syndromes using PET data and a computer system based on support vector machines and Bayesian networks
por: Segovia, Fermín, et al.
Publicado: (2015)

Diagnostic value of micrographia in Parkinson’s disease: a study with [(123)I]FP-CIT SPECT
por: Eklund, Mikael, et al.
Publicado: (2022)

Improving the Convergence Rate in Affine Registration of PET and SPECT Brain Images Using Histogram Equalization
por: Salas-Gonzalez, D., et al.
Publicado: (2013)

Parkinson's Disease Detection Using Isosurfaces-Based Features and Convolutional Neural Networks
por: Ortiz, Andrés, et al.
Publicado: (2019)

Serial I-123-FP-CIT SPECT Image Findings of Parkinson's Disease Patients With Levodopa-Induced Dyskinesia
por: Jeong, Eun Hye, et al.
Publicado: (2018)

Serial changes of I-123 FP-CIT SPECT binding asymmetry in Parkinson's disease: Analysis of the PPMI data
por: Jeong, Eun Hye, et al.
Publicado: (2022)

A new visual rating scale for Ioflupane imaging in Lewy body disease
por: Lloyd, Jim J., et al.
Publicado: (2018)

Multi-Atlas MRI-Based Striatum Segmentation for (123)I-FP-CIT SPECT (DAT-SPECT) Compared With the Bolt Method and SPECT-Atlas-Based Segmentation Method Toward the Accurate Diagnosis of Parkinson's Disease/Syndrome
por: Sohara, Koji, et al.
Publicado: (2021)

[(123)I]-Celecoxib Analogues as SPECT Tracers of Cyclooxygenase-2 in Inflammation
por: Uddin, Md. Jashim, et al.
Publicado: (2010)

Clinicopathological and (123)I‐FP‐CIT SPECT correlations in patients with dementia
por: Jung, Youngsin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_svkab06rbjevbpk5jb1qojh4oj